APA (7th ed.) Citation

Isitman, G., Tremblay-McLean, A., Lisovsky, I., Bruneau, J., Lebouché, B., Routy, J., & Bernard, N. F. (2016). NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. PloS one, 11(10), e0164517. https://doi.org/10.1371/journal.pone.0164517

Chicago Style (17th ed.) Citation

Isitman, Gamze, Alexandra Tremblay-McLean, Irene Lisovsky, Julie Bruneau, Bertrand Lebouché, Jean-Pierre Routy, and Nicole F. Bernard. "NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their IKIR Negative Counterparts." PloS One 11, no. 10 (2016): e0164517. https://doi.org/10.1371/journal.pone.0164517.

MLA (9th ed.) Citation

Isitman, Gamze, et al. "NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their IKIR Negative Counterparts." PloS One, vol. 11, no. 10, 2016, p. e0164517, https://doi.org/10.1371/journal.pone.0164517.